Table 1. Characteristics of CHC patients, CHC patients with HCC and healthy subjects.
| CHC patients (n = 62) | CHC patients with HCC (n = 29) | Healthy subjects (n = 19) | ||
| Age (years) | Mean ± SD | 46.1±11.2 | 61.4±9.1 | 33.2±10.6 |
| Sex (n) | Male | 34 (54.8%) | 22 (75.9%) | 11 (57.9%) |
| Female | 28 (45.2) | 7 (24.1%) | 8 (42.1%) | |
| HAI (n) | 2 | 7 (11.3%) | - | |
| 3 | 8 (12.9%) | - | ||
| 4 | 13 (21.0%) | - | ||
| 5 | 10 (16.1%) | 2 (6.9%) | ||
| 6 | 14 (22.6%) | 1 (3.4%) | ||
| 7 | 5 (8.1%) | 2 (6.9%) | ||
| 8 | 2 (3.2%) | 2 (6.9%) | ||
| 9 | 3 (4.8%) | 2 (6.9%) | ||
| 11 | - | 1 (3.4%) | ||
| Unknown | - | 19 (65.5%) | ||
| Fibrosis (n) | F0 | 7 (11.3%) | - | |
| F1 | 20 (32.3%) | - | ||
| F2 | 4 (6.5%) | - | ||
| F3 | 6 (9.7%) | - | ||
| F4 | 10 (16.1%) | 3 (10.3%) | ||
| F5 | 4 (6.5%) | 1(3.4%) | ||
| F6 | 5 (8.1%) | 9 (31.0%) | ||
| Unknown | 6 (9.7%) | 16 (55.2%) | ||
| ALT (n) | Elevated* | 44 (71.0%) | 24 (82.8%) | |
| Normal | 18 (29.0%) | 5 (17.2%) |
*>35 IU/l female; >50 IU/l male.